Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes
More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of ...
Zawya12d
Boehringer Ingelheim announces the appointment of new General Manager for Saudi Arabia, Gulf, and East Africa
Abdulla also aims to further strengthen relationships with regional governments and key healthcare stakeholders to ensure sustainable patient access to Boehringer Ingelheim’s portfolio of leading ...
Business Insider29d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...
Financial Post29d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...
FierceBiotech29d
Notable Labs files for bankruptcy, ending ambitions for Boehringer cancer drug
Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...
dvm36014d
Boehringer Ingelheim announces research and development facility expansion
The state-of-the-art research and development center in Georgia will help improve the health and wellbeing of animals Boehringer Ingelheim shared earlier this month that it has officially opened the ...
pharmaphorum1d
WCLC: Bayer, Boehringer face off on HER2 cancers
Bayer and Boehringer Ingelheim both had new data on their HER2-targeting small-molecule drugs to present at the World Conference on Lung Cancer (WCLC), hoping to add new oral therapies to the ...
pharmaphorum5d
Boehringer says R&D pipeline is the best in its long history
Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...
Pharmaceutical Technology29d
Boehringer partners WHO Foundation to advance healthcare access
Boehringer Ingelheim partners with the WHO Foundation to financially support WHO’s Fourteenth General Programme of Work (2025 to 2028). Credit: PeopleImages.com – Yuri A/Shutterstock. Boehringer ...
Cambridge University Press21d
An overview of the pathophysiology of agitation in Alzheimer’s dementia with a focus on neurotransmitters and circuits
He has served on speakers bureaus for AbbVie/Allergan, Intra-Cellular Therapies, Karuna Therapeutics, and Lundbeck, and he has received research and/or grant support from Acadia, AbbVie/Allergan, ...
Deadline.com26d
Sebastian Stan Recalls ‘Star Trek’, ‘Green Lantern’ Roles He “Desperately Wanted”
The Golden Globe nominee, who portrays Donald Trump in the Ali Abbasi-helmed film, recently revealed that he was up for starring roles in Star Trek (2009) and Green Lantern (2011) years before ...